Paradromics receives FDA approval for human trials of its speech-restoring brain implant

wired.com [$]

Paradromics received FDA approval to begin human trials for its brain implant designed to restore speech. The Austin-based startup's high-bandwidth device aims to help individuals with severe movement limitations communicate. This development is part of a broader trend of advancements in neurotechnology and medical devices.


With a significance score of 4.9, this news ranks in the top 1.9% of today's 29749 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: